p53 Inhibits α6β4 Integrin Survival Signaling by Promoting the Caspase 3-Dependent Cleavage of AKT/PKB

Autor: Bachelder, Robin E., Ribick, Mark J., Marchetti, Alessandra, Falcioni, Rita, Soddu, Silvia, Davis, Kathryn R., Mercurio, Arthur M.

Publikováno v: The Journal of Cell Biology, 1999 Nov . 147(5), 1063-1072.

Externí odkaz: https://www.jstor.org/stable/1619476

Additional file 1 of SEMA6A/RhoA/YAP axis mediates tumor-stroma interactions and prevents response to dual BRAF/MEK inhibition in BRAF-mutant melanoma

Autor: Loria, Rossella, Laquintana, Valentina, Scalera, Stefano, Fraioli, Rocco, Caprara, Valentina, Falcone, Italia, Bazzichetto, Chiara, Di Martile, Marta, Rosanò, Laura, Del Bufalo, Donatella, Bossi, Gianluca, Sperduti, Isabella, Terrenato, Irene, Visca, Paolo, Soddu, Silvia, Milella, Michele, Ciliberto, Gennaro, Falcioni, Rita, Ferraresi, Virginia, Bon, Giulia

Additional file 1: Supplementary Fig. S1. A: shCtr and SEMA6A-depleted A3 cells plated on poly-l lysine coated slides were treated or not with RhoA activator and stained with anti-YAP (red signal) or B: with Phalloidin (red signal). GFP reporter gene

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6374dec54d6170033f3610d05e9636ca

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Additional file 1 of Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study

Autor: Bon, Giulia, Pizzuti, Laura, Laquintana, Valentina, Loria, Rossella, Porru, Manuela, Marchiò, Caterina, Krasniqi, Eriseld, Barba, Maddalena, Maugeri-Saccà, Marcello, Gamucci, Teresa, Berardi, Rossana, Livi, Lorenzo, Ficorella, Corrado, Natoli, Clara, Cortesi, Enrico, Generali, Daniele, Verde, Nicla La, Cassano, Alessandra, Bria, Emilio, Moscetti, Luca, Michelotti, Andrea, Adamo, Vincenzo, Zamagni, Claudio, Tonini, Giuseppe, Barchiesi, Giacomo, Mazzotta, Marco, Marinelli, Daniele, Tomao, Silverio, Marchetti, Paolo, Valerio, Maria Rosaria, Mirabelli, Rosanna, Russo, Antonio, Fabbri, Maria Agnese, D’Ostilio, Nicola, Veltri, Enzo, Corsi, Domenico, Garrone, Ornella, Paris, Ida, Sarobba, Giuseppina, Giotta, Francesco, Garufi, Carlo, Cazzaniga, Marina, Medico, Pietro Del, Roselli, Mario, Sanguineti, Giuseppe, Sperduti, Isabella, Sapino, Anna, Maria, Ruggero De, Leonetti, Carlo, Leo, Angelo Di, Ciliberto, Gennaro, Falcioni, Rita, Vici, Patrizia

Additional file 1.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d5f5a75045590f8ffc10b4f0deb3407

Tumor-stroma interactions mediated by Semaphorin 6A as a determinant of drug resistance in BRAF-mut melanoma

Autor: Loria, Rossella, Falcone, Italia, Di Martile, Marta, Caprara, Valentina, Fraioli, Rocco, Laquintana, Valentina, Bon, Giulia, Rosano, Laura, Del Bufalo, Donatella, Ciuffreda, Ludovica, Ferraresi, Virginia, Milella, Michele, Falcioni, Rita

Publikováno v: Journal of experimental & clinical cancer research (Online) 80 (2020). doi:10.1158/1538-7445.AM2020-1887
info:cnr-pdr/source/autori:Loria, Rossella; Falcone, Italia; Di Martile, Marta; Caprara, Valentina; Fraioli, Rocco; Laquintana, Valentina; Bon, Giulia; Rosano, Laura; Del Bufalo, Donatella; Ciuffreda, Ludovica; Ferraresi, Virginia; Milella, Michele; Falcioni, Rita/titolo:Tumor-stroma interactions mediated by Semaphorin 6A as a determinant of drug resistance in BRAF-mut melanoma/doi:10.1158%2F1538-7445.AM2020-1887/rivista:Journal of experimental & clinical cancer research (Online)/anno:2020/pagina_da:/pagina_a:/intervallo_pagine:/volume:80

Background: Despite the promise of dual BRAF/MEK inhibition as a therapy for BRAF-mutant (BRAF-mut) melanoma, heterogeneous responses have been observed in patients, thus predictors of benefit from therapy are needed. We have previously identified se

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=cnr_________::014a338f1e4e953fbb1f89494c862de9
http://www.cnr.it/prodotto/i/466737